SLTFF yields 4081.63% · JNJ yields 2.13%● Live data
📍 SLTFF pulled ahead of the other in Year 1
Combined, SLTFF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SLTFF + JNJ for your $10,000?
Pegasus Resources Inc., a diversified junior mining company, engages in the acquisition, exploration, and development of mineral properties in North America. The company primarily focuses on the optioned properties in Confederation Lake project, which include the Garnet Lake/Arrow Zone property; Fredart and Copperlode property; Dixie property; Joy North property; North Pakwash Lake; and Mitchell, Gerry Lake and Karas Lake properties located in Ontario. It also holds interests in the Golden gold/silver and copper project located along the British Columbia, and Energy Sands project located in Emery County, Utah; and option agreements to acquire 100% interests in the Millionara gold property, Pine Channel Property, Chord Property, Lucky 7 Property, AurCrest Property, James Bay property, and Icefield gold property. Further, it focuses on blockchain applications for mining and resource company management. The company was formerly known as Pistol Bay Mining Inc. and changed its name to Pegasus Resources Inc. December 2020. Pegasus Resources Inc. was incorporated in 1995 and is headquartered in Vancouver, Canada.
Full SLTFF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.